Dyslipidemia Management in PAD

• Peripheral artery disease (PAD) is a highly prevalent atherosclerotic syndrome and is associated with significant disability, morbidity and mortality.

• PAD still largely remains underdiagnosed, understudied and undertreated.

• Despite the significant limb and CV outcomes in PAD, there is poor risk factor modification relative to other atherosclerotic diseases like CAD or stroke.

• Initiate HIS in patients with PAD once diagnosed.

• Classify the PAD patient in one of the ASCVD risk categories based on related ASCVD risk factors and other comorbidities. Define the goal of LDL-C based on the ASCVD risk category.

• Send extended lipid profile including LP(a) assessment.

• If there is a greater reduction of LDL-C required according to the lipid profile report, other nonstatin drugs may be used in addition to HIS.